In October, due to demand from existing healthcare partners, CTS began testing blood donors for antibody to Babesia microti under an Investigational New Drug exemption as a release test.
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...